Analysis and thoughts on the 2nd year quarterly, page-9

I am down a very significant amount and have been holding nor for many many months now, and was indeed told that the current corona revenue is small, nothing substantial at all. Initial companies trialing Corona 1 no longer involved as product Corona 1 is being revamped into the newer version that is currently being developed.

I really feel for all those invested in Nor at higher prices, I feel your pain. In my opinion now , Corona will be used by smaller subscribers until the product is proven over many months and then hopefully there are no technical issues so bigger companies who have international exposure are more confident in the product.